18 /100
LOW RISK
Score updated Jul 13, 2026

PLX — Protalix BioTherapeutics, Inc. Dilution Risk Tracker

Track PLX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PLX — Get alerts when the score changes →

As of July 13, 2026, Protalix BioTherapeutics, Inc. (PLX) has a DilutionWatch DilutionScore of 18/100, rated LOW dilution risk. Protalix BioTherapeutics, Inc. has a market capitalization of $170.01M, 80.57M shares outstanding, 100 institutional holders tracked. Key dilution vectors include 845.0K outstanding warrants, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for PLX.
🔔 Track PLX — Get forecast alerts →

💹 Market Data

Market Cap$170.01M
Shares Outstanding80.57M
Float72.73M
Cash$41.00M
Debt$912.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 36.0% shares (2026Q1 vs prior)
100 institutional holders · 20.68M shares
#1 BlackRock, Inc. 3.62M shares
#2 MAK CAPITAL ONE LLC 3.54M shares
#3 Opaleye Management Inc. 2.82M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.56M
Days to Cover4.2
% of Float4.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for PLX Shareholders

Protalix BioTherapeutics, Inc. (PLX) has a DilutionScore of 18/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 845,000 outstanding warrants for PLX. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for PLX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for PLX alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track PLX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PLX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for PLX
📊 PLX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PLX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.